ArticlePDF AvailableLiterature Review

Abstract and Figures

The aim of this study is to evaluate the efficacy of low-level laser therapy (LLLT) in patients with Bell’s palsy (BP) through a systematic review method. We systematically searched international databases including PubMed, Scopus, and Web of Science to find eligible articles without language limitation. All relevant randomized controlled trials (RCTs) that compared the efficacy of the LLLT with placebo laser, exercise, massage, or no intervention on BP patients were included. Four studies (out of 259) had met our inclusion criteria involving 171 patients and were entered to the systematic review. Full texts of the selected studies were retrieved and critically appraised using Physiotherapy Evidence Database (PEDro) scale. The patients of all trials were in sub-acute (less than 1 week) stage. Both of LLLT and control groups showed significant improvement after trials. Two authors reported significant differences between the groups after 6 weeks of laser application (830 nm, 100 mW). In converse, two other authors did not identify any effectiveness following 4 weeks and 15 days of LLLT application with 670 and 830 nm wavelength, sequentially. There is clear lack of information lead to get and evidence-based suggestion for the LLLT application on Bells’ palsy; however, the LLLT irradiation with 830 nm and 100 mW power for a period of 6 weeks might be beneficial on recovery for the patients with sub-acute Bell’s palsy. There were no reported adverse effects during treatment and/or follow-up sessions.
Content may be subject to copyright.
REVIEW ARTICLE
Efficacy of low-level laser therapy on management of Bellspalsy:
a systematic review
Mohammad Javaherian
1
&Behrouz Attarbashi Moghaddam
1
&Siamak Bashardoust Tajali
1
&
Narges Dabbaghipour
1
Received: 1 June 2019 /Accepted: 9 March 2020
#Springer-Verlag London Ltd., part of Springer Nature 2020
Abstract
The aim of this study is to evaluate the efficacy of low-level laser therapy (LLLT) in patients with Bells palsy (BP) through a
systematic review method. We systematically searched international databases including PubMed, Scopus, and Web of Science
to find eligible articles without language limitation. All relevant randomized controlled trials (RCTs) that compared the efficacy
of the LLLT with placebo laser, exercise, massage, or no intervention on BP patients were included. Four studies (out of 259) had
met our inclusion criteria involving171 patients and were entered to the systematic review. Full texts of the selected studies were
retrieved and critically appraised using Physiotherapy Evidence Database (PEDro) scale. The patients of all trials were in sub-
acute (less than 1 week) stage. Both of LLLT and control groups showed significant improvement after trials. Two authors
reported significant differences between the groups after 6 weeks of laser application (830 nm, 100 mW). In converse, two other
authors did not identify any effectiveness following 4 weeks and 15 days of LLLTapplication with 670 and 830 nm wavelength,
sequentially. There is clear lack of information lead to get and evidence-based suggestion for the LLLT application on Bells
palsy; however, the LLLT irradiation with 830 nm and 100 mW power fora period of 6 weeks might be beneficial on recovery for
the patients with sub-acute Bells palsy. There were no reported adverse effects during treatment and/or follow-up sessions.
Keywords Low-level laser therapy .Facial palsy .Bellspalsy .Physiotherapy
Introduction
Idiopathic peripheral facial palsy or Bells palsy (BP) is an
acute, unilateral common syndrome that affects half of facial
muscles and might lead to their paralysis [1,2]. Since the
facial muscles have major role in human communications,
BP may cause psychological and social problems [1].
Additionally, BP may cause many problems in eating, drink-
ing, speaking, and eye closure [3].
BP is associated with inflammation process of peripheral
part of facial nerve. Besides, it is different from other types of
facial palsies since it is categorized as an idiopathic disorder
[4,5]. Theoretically, it can be raised by infection,
compression, micro-trauma, autoimmune, or even genetic rea-
sons [6,7]. Some evidences suggested that herpes simplex
virus-1 reactivation at the cranial nerve is a most strongly
suspected cause of facial nerve inflammation in BP [8].
The annual incidence of BP is 23 to 35 cases per 100,000
with an equal gender ratio. It is thought that 5075% of acute
unilateral facial paralysis appeared between 30 and 50 years
old [9,10]. The BP prognosis is relevant to the factors such as
time of recovery, age, pain behind of ear, taste distribution,
and genetics [9,11].
Several care methods have been suggested as treat-
ment approaches for the BP. Corticosteroid drugs and
acupuncture have been indicated as the effective modal-
ities for the BP treatment [12,13]. Turgeon et al. pro-
vided a relevant systematic review and reported that an-
tiviral agents might not be effective on the BP recovery
[14]. There are three other group of researchers who
systematically reviewed trials that report effects of elec-
trical stimulation, biofeedback, ultrasound, laser, and
short-wave diathermy on the BP treatment [2,10,15].
These researchers did not clarify clear distinct conclusion
*Siamak Bashardoust Tajali
s_bashardoust@sina.tums.ac.ir
1
Department of Physiotherapy, School of Rehabilitation, Tehran
University of Medical Sciences, Tehran, Iran
Lasers in Medical Science
https://doi.org/10.1007/s10103-020-02996-2
to suggest best effective physiotherapy methods of care
for the patients with the BP. Some of the selected trials
had been designed with a poor methodological concerns
such as lack of accepted facial function grading systems,
frequent failure to distinguish complete from functional
recovery, and inconsistent follow-up [15]. Pereira et al.
evaluated influence of exercise therapy associated or not
with mirror biofeedback. This researcher suggested this
method as an effective treatment for functional improve-
ment in patients with BP [2]. Teixeira et al. reviewed
efficacy of different physical therapy interventions for
the BP patients and concluded that there were no high-
quality evidences to support significant benefit or harm
for the identified interventions including acupuncture,
electrotherapy, and biofeedback. However, there were
low-quality evidences that show effects of exercise ther-
apy on functional improvement in patients with the BP
[10].
Some evidences suggested low-level laser therapy (LLLT)
as a useful modality for peripheral nerve anti-inflammation,
repair, regeneration, axonal growth, and myelination [16,17].
Also, specific dosages of LLLT were suggested to be applied
at nerve inflammation disorders such as trigeminal neuralgia
or carpal tunnel syndrome [18,19].
According to previous literatures, the LLLT provides
photons on the mitochondria in cells; the photon energy
will be absorbed by cytochrome c oxidase, which is the
last enzyme in the electron transportation chain, playing
an essential role in the oxygenation metabolism and pro-
duction of ATP. The more photons being absorbed by
cytochrome c oxidase, the more oxidized (activated) state
cytochrome c oxidase will be [20,21]. Therefore, the
accelerated oxygenation process and extra production of
ATP will then help the cells and tissues [22].
The LLLT has also been suggested for management of the
BP in some case reports, case series, clinical trials, and ran-
domized controlled trials (RCTs). All previous reviews, in-
cluding studies with the LLLT [10,15], can be categorized
as low-quality evidences. As a result, the authors did not
strongly suggest the LLLT application at patients with the
BP. Therefore, the need of a study with higher level of evi-
dence is felt in order to evaluate the effects of LLLT in BP
patients. Thus, the aim of this study is evaluating the efficacy
of the LLLT in patients with the BP through a systematic
review method.
Methods
Searching method
Two researchers independently searched three relevant inter-
national databases to identify potential relevant studies. The
authors searched PubMed (title/abstract), Scopus (title/ab-
stract/keyword), and Web of Science (topic) from 1980 to
July 2018. To identify suitable keywords, Bells palsy and
LLLT were searched in Medical Subject Heading (MeSH),
and their synonyms were applied for database searching.
The selected keywords were (LaserOR phototherapy*
OR photo therap) AND (bells palsyOR bells palsy
Fig. 1 Flowchart for the identification of the eligible studies evaluating the effect of the LLLTon BP
Lasers Med Sci
OR facial neuropathOR facial paralOR Facial pals).
The authors also provided hand search of the references of the
selected studies to identify other possible relevant studies.
Selection of studies
Two authors independently reviewed the title and abstract of
all identified articles from systematic and included potentially
relevant articles. The authors obtained full texts of all potential
relevant abstracts and independently reviewed them to identi-
fy inclusion/exclusion criteria. In the next stage, the authors
critically appraised the selected manuscripts by Physiotherapy
Evidence Database (PEDro) scale and provided a quality
score for each included study. There was an agreement session
that was held to resolve any disagreement between the
authors.
Inclusion/exclusion criteria
Type of studies
The published randomized controlled trials (RCTs) in any
language that report effects of the LLLT application on
Bells palsy were included in this systematic review. All se-
lected studies must have at least one control group receiving
placebo laser, exercise, massage, or no intervention.
Type of participants
The patients with idiopathic peripheral facial palsy (IPFP) in
any sex, gender, and age under the LLLT application were
considered as inclusion criteria in this systematic review. We
included studies with participants in all stages of the BP. The
BP diagnosis methods were not considered as an inclusion
criteria.
Type of intervention
The authors included all trials using any type of the LLLT
application with different wavelengths and output power less
than 500 mW, provided that the experimental groups did not
receive any further treatment such as corticosteroid therapy.
The studies compared the LLLT with exercise and/or massage
as control groups were entered into the systematic review.
Any laser acupuncture study was excluded from final results.
Outcome measurements
Any type of outcome measurement was accepted to the cur-
rent study.
Table 1 Summary of methodological properties for included studies
Author Study design Sample
size (T/C)
Age (years) Phase of disease Intervention/s of LLLTG Intervention/s of CG Duration
of Tx
Number of total
sessions/ frequency
(S/W)
Ordahan et al.
(2017) [32]
RCT 46 (23/23) Mean ± SD,
45 ±22
Sub-acute LLLT + facial exercise (active assistive,
resistive, and PNF exs. in front of mirror)
Facial exs. 6 weeks 30/5
Alayat et al. (2014)
[33]
Double-blind
RCT
31 (15/16) NM Sub-acute
(35days
after onset)
LLLT + facial massage + facial exs.
(active, active assistive, resistive, PNF,
and resisted exercise for neck muscles)
Sham laser, Facial massage,
Facial exs.
6 weeks 18/3
Delgado Castillo
et al. (2013) [31]
Simple-blind
RCT
73 (38/35) NM Sub-acute (less
than 1 week )
LLLT + facial massage + facial exs. Facial massage + Facial exs. 4 weeks 20/5
MacÍas-Hernández
et al. (2012) [34]
Double-blind
RCT
21 (11/10) Median
LLLTG 38,
CG 48
Sub-acute (less
than 1 week )
LLLT + facial massage + facial exs.
(stretching and re-education of facial
muscles in front of a mirror)
Sham laser + Superficial heat +
Facial massage + Facial exs.
15 days 15/7
RCT randomized controlled trial, Ttreatment, Ccontrol, NM not mentioned, LLLT low-level laser therapy, LLLTG low-level laser therapy group, CG control group, PNF proprioceptive neuromuscular
facilitation, exs exercise, S/W sessions per week
Lasers Med Sci
Quality assessment
Two researchers independently read the selected full texts,
appraised them critically, and scored their quality based on
PEDro quality assessment tool [23,24]. Any disagreement
was discussed between the authors, and final scores were
obtained.
Data collection
A data extraction form was designed to clarify the details for
each study. Two authors independently read full text ofinclud-
ed articles and extracted all obtainable characteristics for each
study, including design and blinding, sample size, phase of
disease, accompanying interventions both for laser and control
groups, number of sessions, period and frequency of treat-
ment, technical properties of laser, outcome measures, assess-
ment time, and final results. We used Google Translate online
software for data extraction of studies with non-English lan-
guage [25,26]. Alpha equal or less than 0.05 was considered
as significant difference in data extraction.
Results
We identified 259 abstracts based on the identified keywords
and the selected international databases. After the initial re-
view, there were 9 potentially relevant abstracts which were
selected to be fully retrieved. The selected 9 full manuscripts
were critically reviewed base on the inclusion/exclusion
criteria. Finally, there were 4 identified relevant manuscripts
that were critically appraised by two independent researchers.
In total, 250 studies did not meet the inclusion criteria and
were excluded. The most important reasons of exclusion of
studies were not meeting their type of patients to our criteria
[2729], lack of proper control group [30], and combination
of two modalities in intervention group [31]. Finally, four
RCTs were included to our study [3134].
There was no study added to the selected studies following
hand search. The flowchart of the database search and selec-
tion criteria is shown in Fig. 1.
Quality of the selected studies
The PEDro scales of included studies were varied from 7 to
10. Details of quality assessment are presented in Table 1.
Characteristics of the selected studies
Summaryofmethodologicalpropertiesofincludedstudiesis
presented in Table 2. There were two English [32,33] and two
Spanish [31,34] selected studies in our final review. Two
studies were designed as controlled, double-blinded RCTs that
one of them had patients and therapist blinding [33] and the
other had patients and assessor blinding [34]. Another group
of researchers followed simple blinding, but they did not iden-
tify who was blinded to their patient allocation [31].
Through the selected four studies, 87 and 84 patients were
consideredfor the LLLT and control groups, respectively. Two
studies had two parallel RCT design, the LLLT group and
control group [32,34]. One study had three parallel RCT
design including high-level laser therapy, LLLT group, and
Table 2 Quality assessment of included articles based on PEDro scale
Item Study ID
Ordahan et al. (2017)
[32]
Alayat et al. (2014)
[33]
Delgado Castillo et al.
(2013) [31]
MacÍas-
Hernández
et al. (2012)
[34]
Eligibility criteria specification Yes Yes Yes Yes
Proper random allocation Yes Yes Yes Yes
Allocation concealment Yes Yes No No
Groups similarity at baseline Yes Yes Yes Yes
Subjects blinding No Yes No Yes
Therapists blinding No Yes No No
Assessor blinding No No No Yes
Outcome measure obtaining from 85% subjects initially
allocated to groups
Yes Yes Yes Ye s
Use of intention to treat analysis Yes Yes Yes Yes
Reporting between group statistical comparisons Yes Yes Yes Yes
Reporting point measures and measures of variability Yes No Yes No
Total 8 10 7 8
Lasers Med Sci
control group [33]. There was one study using different inter-
ventions including conventional therapy (CT), magnetic field
therapy (MFT) + CT, LLLT + CT, and MFT + LLLT + CT
which we considered the LLLT + CT and CT groups as inter-
vention and control groups, respectively [31]. All studies
started treatment in sub-acute phase.
All researchers applied both exercise and massage therapy
in their control groups among all selected trials. The identified
exercise and massage therapy were accompanied as parts of
their care methods in the intervention groups. The period of
the treatment sessions were varied from 15 days to 6 weeks,
provided 15 to 30 sessions for the patientstreatment.
Laser properties of the selected studies
All identified researchers applied pencil-like method on facial
nerve roots, while most of them applied 830 nm wavelengths
for their laser application. Table 3summarizes laser properties
of included studies. Some variables like number of emitters,
emitter type, beam delivery system, central wavelength, spec-
tral bandwidth, energy per pulse, polarization, average radiant
power, and beam divergence were not reported in the included
studies [35].
Outcome measures and results
The only common outcome measure was facial disability in-
dex (FDI) which was divided to physical and social FDI
(PFDI and SFDI) and was reported in two studies [32,36].
Researchers of these studies reported significant improvement
(SI) on the FDI following laser therapy at the ending of their
treatment sessions (6 weeks).
Alayat et al. applied House-Brackmann scale for as-
sessment and showed similar results to the FDI scores.
However, they reported improvement of both scores over
time in the LLLT and control group, but their scores show
downward trend over time, unexpectedly. In total, laser
application was able to reduce downward trend of FDI
in the LLLT group; therefore, there is significant differ-
ence between the groups at 6 weeks. Table 4shows the
PFDI and SFDI scores which were extracted from the
studies by Ordahan et al. and Alayat et al.
Delgado Castillo et al. assessed patients by Sunnybrook
facial grading system at baseline, end of treatment (4 weeks),
and 12 weeks following the interventions [31]. He reported
that both groups had been improved following laser
application.
MacÍas-Hernández et al. used four outcome measures at
baseline, end of treatment sessions (15 days), and 30 and
60 days after interventions. This researcher reported muscle
and perception improvement following 15 sessions of LLLT
held through 15 days and also in control group. We did not
find statistical results of within group analysis in this study
Table 3 Technical properties of laser used in included articles
Study ID Type of laser Wavelength
(nm)
Frequency (Hz) Duty
cycle
(%)
Time of each point (s)/number
of points/total time (s)
Location of point(s) Set power (mW)/energy density
(J/cm
2
)/total energy (J)
Ordahan et al. (2017)
[32]
GaAlAs
(infrared)
diode
830 1000 NM 120/8/960 Superficial roots of the facial nerve on the
affected side
100/10/80
Alayat et al. (2014)
[33]
GaAs
(infrared)
830 1000 80 125/8/1000 Superficial roots of the facial nerve on the
affected side
100/NM/80
Delgado Castillo
et al. (2013) [31]
NM 670 NM, but mentioned
laser was pulsatile
NM starting with 30 s and increase
15 s every 5 sessions until
reachto1m/NM/NM
Through the course of facial nerve with
1.5-cm space between two points and
extra point at nerve exit locale
40/14/NM
MacÍas-Hernández
et al. (2012) [34]
GaAlAs 830 NM NM NM/NM/NM In the emergence of facial nerve 30/20/NM
GaAlAs gallium-aluminum-arsenide, GA gallium-arsenide, nm nanometer, NM not mentioned, Ssecond, Jjoule, mW milliwatt
Lasers Med Sci
between the baseline and end of treatment. There were no
significant differences between the groups, except improve-
ment of perception for the LLLT group after 60 days. All
patients in both groups had normal palpebral occultation with-
out any epiphora and dysgeusia following 30 days of inter-
ventions. All results of included studies are summarized in
Table 5.
Discussion
This study was designed as a systematic review to evaluate
effects of LLLT application on Bells palsy recovery. Totally,
four manuscripts met our inclusion criteria including 171 pa-
tients suffering sub-acute Bellspalsy. Two researchers had
been applied the GaAlAs laser (wavelength 830 nm) for a
period of 6 weeks and reported statistically significant effects
following the LLLT application on Bellspalsy. Conversely,
Delgado Castillo et al. did not identify any effectiveness fol-
lowing 4-week LLLT application (wavelength 670 nm) on
Bells palsy. The other identified researcher (Hernanzed
et al., 2012) did not report any difference between the groups
for all objective outcome measures following 15 days of the
LLLT application (wavelength 830 nm).
The researchers of all included trials had used facial exer-
cises in both LLLT and control groups. Although the presence
of exercise therapy is due to ethical aspects of studies, we
should pay attention to its major influence on patientsfunc-
tional improvement [2]. This effect might be the reason to lead
to levels of patients improvement in control groups.
Accordingly, between group analysis can show us a more
transparent effect of LLLT for BP in included studies.
Table 4 FDI scores of studies by Ordahan et al. and Alayat et al.
Study Groups PFDI SFDI
Before 3 weeks 6 weeks Before 3 weeks 6 weeks
Ordahan et al. (2017) [32] LLLTG 27.05± 14.13 37.42 ± 8.13 39.21 ± 9.08 22.80 ± 18.76 35.41 ± 10.12 37.53 ± 9.65
CG 26.52 ± 11.07 25.41 ± 13.12 29.06 ± 11.09 23.40 ± 15.23 23.25± 15.27 28.76 ± 12.14
Alayat et al. (2014) [33] * LLLTG 27.06 25.53 21.8 28.77 22.33 25.73
CG 26.84 9.81 10.84 23.25 10.91 8.5
PFDI, physical facial disability index; SFDI, social facial disability index; LLLTG, low-level laser therapy group; CG, control group
*
SD has not been reported
Table 5 Summary of results and finding of included studies
Study ID Outcome measurements Assessment times Summary of results
Ordahan et al. (2017)
[32]
FDI (PFDI, SFDI) Before, 3 and
6weeks
LLLTG: SI at 3 and 6 weeks
CG: No improvement (exception BTW baseline
and 6 weeks)
Higher FDI at 3 and 6 weeks in LLLT
Alayat et al. (2014) [33]FDI (PFDI, SFDI)
HBS
Before, 3 weeks,
6weeks
LLLTG: SI of both scores at 3 and 6 weeks with greatest
improvement at 6 weeks.
CG: FDI and HBS after 3 and 6 weeks
Higher FDI 3 and 6 weeks in the LLLT. Higher HBS 6
weeks in the LLLT (No effect on HBS after 3 weeks of irradiation)
Delgado Castillo et al.
(2013) [31]
Sunnybrook facial
grading system
Before, 4 weeks,
12 weeks
LLLTG: SI at 4 and 12 weeks with greatest improvement at 12 weeks.
CG: SI at 4 and 12 weeks with greatest improvement at 12 weeks.
BGA: No significant difference between groups at 4 and 12 weeks.
MacÍas-Hernández
et al. (2012) [34]
MMT of 18 facial
muscles
Presence of epiphora
and dysgeusia
Palpebral occlusion
capacity (mm)
% of improvement
(self-assessment)
Before, 15, 30,
and 60 days
LLLTG: All outcomes improved at 60 days than baseline.
CG: All outcomes improved at 60 days than baseline.
BGA: NS for all outcome measures BTW groups (exception of improvement
perception for the LLLT after 60 days).
NS on palpebral occultation and no difference on number of patients
with epiphora and dysgeusia between the groups after 15 days.
All patients were fine 30 days following interventions.
FDI facial disability index, PFDI physical facial disability index, SFDI social facial disability index, HBS House-Brackmann scale, MMT manual muscle
testing, mm millimeter, VAS visual analogue scale, LLLTG low-level laser therapy group, CG control group, BGA between group analysis, SI significant
improvement
Lasers Med Sci
Current evidences show that it seems that the use of 830 nm
LLLT with 100 mWoutput and 120-s duration oneight points
of facial branches of affected site during6 weeks can positive-
ly influence on function of patients with BP in sub-acute stage.
However, generalization of the results of the current study
should be done with caution, because we could find only four
RCTs which two of them did not show statistically significant
difference between groups. None of included studies showed
any adverse effect of LLLT during treatment and follow-up.
Murakami et al. compared efficacy of stellate ganglion
block (SGB), infrared diode laser (830 nm), and combination
of both of them in patients with sub-acute BP in a clinical trial.
Their results showed that patients in LLLT group demonstrat-
ed faster initial recovery and slightly better final paralysis
scores than other groups [30]. Ladarlo et al. reported 4 patients
with BP who have undergone LLLTwith 780-nm wavelength
(GaAlAs) during 24 sessions with 2 sessions per week fre-
quency. They have mentioned the use of electrophysiology
examinations accompanying to HBS before and after of treat-
ment, but exact type of electrophysiology examination is not
reported. They indicated that all cases had abnormal blink
reflex before treatment, but all were normal after treatment
[37]. Fontana and Bagnato reported influence of LLLT on a
child patient with BP. They used GaAlAs diode laser (660 and
780 nm) during 11 sessions with 4 sessions per week frequen-
cy. The patient showed complete recovery after this treatment
method [38].
All included studies started treatments in sub-acute stage of
BP, and we do not have any information about its effective-
ness in chronic stage. NG and Shu reported two cases with
acute and chronic BP who have undergone 6 weeks treatment
by 890 nm LLLT and chiropractic techniques. Acute case
showed 95% improvement after 6 weeks, and chronic case
demonstrated 50% improvement after similar period [39].
Our study has some limitations which should be noted.
First, we only included RCTs that led to small number of
included studies, therefore made generalization of the results
difficult. Other relevant studies were mostly case report or
case series that rank lowly in level of evidences. From another
way, this limitation caused conducting meta-analysis impossi-
ble. Second, included studies mostly used non-parametric
tests for statistical analysis that reduce power of analysis. It
may be that this is due to small number of sample sizes of most
studies. Third, study by MacÍas-Hernández et al. did not men-
tion laser properties which had been used; therefore, we could
not find other reasons for insignificant results of between
group analysis except treatment duration [34]. Fourth, we
did not find a study with electrophysiology evaluation as a
reliable and accurate tool for assessment and prognosis of
patients with BP [40].
Further studies are needed in order to overcome limitations
with the following recommendations. First, more RCTs with
enlarged sample sizes compared LLLT with other standard
modalities. Second, studies should pay more attention to study
design, use sham laser, and perform blinding, allocation con-
cealment, proper randomization, and proper statistical analy-
sis. Moreover, explanation of complete properties of laser is
very important. Third, we need more studies evaluating effi-
cacy of LLLT on chronic BP. Fourth, other objective outcome
measures such as electrophysiological evaluation should be
assessed.
Conclusion
In summary, few available relevant evidences cautiously sug-
gested that the GaAlAs laser application (wavelength 830 nm,
80 J total energy per session, for a period of 6 weeks) can
effectively improve patients with sub-acute Bellspalsy.
Limited number of eligible studies and lack of applied laser
characteristics did not let the authors to provide a meta-
analysis to reach better clarification.
Compliance with ethical standards
Conflict of interests The authors declare that they have no conflict
interest.
References
1. Ho AL, Scott AM, Klassen AF, Cano SJ, Pusic AL, Van Laeken N
(2012) Measuring quality of life and patient satisfaction in facial
paralysis patients: a systematic review of patient-reported outcome
measures. Plast Reconstr Surg 130(1):9199
2. Pereira L, Obara K, Dias J, Menacho M, Lavado E, Cardoso J
(2011) Facial exercise therapy for facial palsy: systematic review
and meta-analysis. Clin Rehabil 25(7):649658
3. Eviston TJ, Croxson GR, Kennedy PG, Hadlock T, Krishnan AV
(2015) Bells palsy: aetiology, clinical features and multidisciplin-
ary care. J Neurol Neurosurg Psychiatry:jnnp-2014-309563
4. Peitersen E (2002) Bells palsy: the spontaneous course of 2,500
peripheral facial nerve palsies of different etiologies. Acta
Otolaryngol 122(7):430
5. Danner CJ (2008) Facial nerve paralysis. Otolaryngol Clin N Am
41(3):619632
6. Gilden DH (2004) Bells palsy. N Engl J Med 351(13):13231331
7. Knox GW (1998) Treatment controversies in Bell palsy. Arch
OtolaryngolHead Neck Surg 124(7):821823
8. Zandian A, Osiro S, Hudson R, Ali IM, Matusz P, Tubbs SR,
Loukas M (2014) The neurologists dilemma: a comprehensive
clinical review of Bells palsy, with emphasis on current manage-
ment trends. Med Sci Monitor: Int Med J Exp Clin Res 20:83
9. Katusic SK, Beard CM, Wiederholt W, Bergstralh EJ, Kurland LT
(1986) Incidence, clinical features, and prognosis in Bellspalsy,
Rochester, Minnesota, 19681982. Ann Neurol 20(5):622627
10. Teixeira LJ, Valbuza JS, Prado GF (2011) Physical therapy for
Bells palsy (idiopathic facial paralysis). Cochrane Database Syst
Rev. https://doi.org/10.1002/14651858.CD006283.pub3
11. Danielidis V, Skevas A, Van Cauwenberge P, Vinck B (1999) A
comparative study of age and degree of facial nerve recovery in
Lasers Med Sci
patients with Bells palsy. Eur Arch Otorhinolaryngol 256(10):520
522
12. Salinas RA, Alvarez G, Daly F, Ferreira J (2010) Corticosteroidsfor
Bells palsy (idiopathic facial paralysis). Cochrane Database Syst
Rev. https://doi.org/10.1002/14651858.CD001942.pub4
13. LiP, Qiu T, Qin C (2015) Efficacy of acupuncture for Bellspalsy:a
systematic review and meta-analysis of randomized controlled tri-
als. PLoS One 10(5):e0121880
14. Turgeon RD, Wilby KJ, Ensom MH (2015) Antiviral treatment of
Bells palsy based on baseline severity: a systematic review and
meta-analysis. Am J Med 128(6):617628
15. Quinn R, Cramp F (2003) The efficacy of electrotherapy for Bells
palsy: a systematic review. Phys Ther Rev 8(3):151164
16. Barbosa RI, Marcolino AM, de Jesus Guirro RR, Mazzer N,
Barbieri CH, Fonseca MCR (2010) Comparative effects of wave-
lengths of low-power laser in regeneration of sciatic nerve in rats
following crushing lesion. Lasers Med Sci 25(3):423430
17. Chow R, Armati P, Laakso E-L, Bjordal JM, Baxter GD (2011)
Inhibitory effects of laser irradiation on peripheral mammalian
nerves and relevance to analgesic effects: a systematic review.
Photomed Laser Surg 29(6):365381
18. Falaki F, Nejat AH, Dalirsani Z (2014) The effect of low-level laser
therapy on trigeminal neuralgia: a review of literature. J Dental Res
Dent Clin Dent Prospects 8(1):1
19. Bekhet AH, Ragab B, Abushouk AI, Elgebaly A, Ali OI (2017)
Efficacy of low-level laser therapy in carpal tunnel syndrome man-
agement: a systematic review and meta-analysis. Lasers Med Sci
32(6):14391448
20. Hwang K, Kim SG, Kim DJ (2008) Hypoglossal-facial nerve anas-
tomosis in the rabbits using laser welding. Ann Plast Surg 61(4):
452456. https://doi.org/10.1097/SAP.0b013e31815f12a5
21. Wang X, Tian F, Reddy DD, Nalawade SS, Barrett DW, Gonzalez-
Lima F, Liu H (2017) Up-regulation of cerebral cytochrome-c-
oxidase and hemodynamics by transcranial infrared laser stimula-
tion: a broadband near-infrared spectroscopy study. J Cereb Blood
Flow Metab 37(12):37893802
22. de Freitas LF, Hamblin MR (2016) Proposed mechanisms of
photobiomodulation or low-level light therapy. IEEE J Select
Topics Quant Electron 22(3):348364
23. de Morton NA (2009) The PEDro scale is a valid measure of the
methodological quality of clinical trials: a demographic study.
Australian J Physiother 55(2):129133
24. Sforza C, Frigerio A, Mapelli A, TarabbiaF, Annoni I, Colombo V,
Latiff M, Pimenta Ferreira CL, Rabbiosi D, Sidequersky FV, Zago
M, Biglioli F (2015) Double-powered free gracilis muscle transfer
for smile reanimation: a longitudinal optoelectronic study. J Plast
Reconstr Aesthet Surg 68(7):930939. https://doi.org/10.1016/j.
bjps.2015.03.029
25. Balk E, Chung M, Chen M, Trikalinos T, Kong W (2013) Assessing
the accuracy of google translate to allow data extraction from trials
published in non-english languages. Agency for Healthcare
Research and Quality (US), Rockville
26. Cruccu G, Pennisi E, Truini A, Iannetti GD, Romaniello A, Le Pera
D, De Armas L, Leandri M, Manfredi M, Valeriani M (2003)
Unmyelinated trigeminal pathways as assessed by laser stimuli in
humans. Brain 126(Pt 10):22462256. https://doi.org/10.1093/
brain/awg227
27. Calderhead RG, Kim WS, Ohshiro T, Trelles MA, Vasily DB
(2015) Adjunctive 830 nm light-emitting diode therapy can im-
prove the results following aesthetic procedures. Laser Ther
24(4):277289. https://doi.org/10.5978/islsm.15-OR-17
28. El-Habashy HR, El-Negmy E, El-Moteleb LA, El-Hadidy R, Hafad
M (2012) Effect of laser therapy on electrophysiological parameters
in children with facial palsy. Egyp J Neurol Psychiatry Neurosurg
49(1):712
29. Kiebzak W, Szmigiel C, Śliwiński Z, Zi ba M (2006) A comparison
of conceptions concerning rehabilitation following facial nerve in-
juries in children. Fizjoterapia Polska 6(1):2226
30. Murakami F, Kemmotsu O, Kawano Y, Matsumura C, Kaseno S,
Imai M (1993) Diode low reactive level laser therapy and stellate
ganglion block compared in the treatment of facial palsy. Laser Ther
5(3):131135
31. Delgado Castillo M, Sanchez del Rio M, de Jesús Díaz García A,
González Quevedo A, Sánchez López JV (2013) Usefulness of
magnetic field and laser for the treatment of idiopathic peripheral
facial palsy. Fisioterapia 35(6):252257. https://doi.org/10.1016/j.
ft.2012.11.004
32. Ordahan B, Karahan AY (2017) Role of low-level laser therapy
added to facial expression exercises in patients with idiopathic fa-
cial (Bells) palsy. Lasers Med Sci 32(4):931936. https://doi.org/
10.1007/s10103-017-2195-9
33. Alayat MS, Elsodany AM, El Fiky AA (2014) Efficacy of high and
low level laser therapy in the treatment of Bells palsy: a random-
ized double blind placebo-controlled trial. Lasers Med Sci 29(1):
335342. https://doi.org/10.1007/s10103-013-1352-z
34. MacÍas-Hernández SI,Lomelí-Rivas A, Baños T, Flores J, Sánchez
M, Miranda-Duarte A (2012) Effects of low power laser in the
treatment of acute peripheral facial paralysis. Rehabilitacion
46(3):187192. https://doi.org/10.1016/j.rh.2012.05.010
35. Jenkins PA, Carroll JD (2011) How to report low-level laser therapy
(LLLT)/photomedicine dose and beam parameters in clinical and
laboratory studies. Photomed Laser Surg 29(12):785787
36. Alay C, Yalçindâ FN (2013) Bells palsy during interferon alpha 2a
treatment in a case with Behçet uveitis. F1000Research 2. https://
doi.org/10.12688/f1000research.2-245.v1
37. Ladalardo TC, Brugnera A, Takamoto M, Pinheiro ALB, de
Carvalho Campos RA, Garrini AEC, Bologna ED, Settanni F
(2001) Functional and electrophysiological evaluation of the effect
of laser therapy in the treatment of peripheral facial paralysis. In:
Lasers in Dentistry VII. International Society for Optics and
Photonics, pp 134139
38. Fontana CR, Bagnato VS (2013) Low-level laser therapy in pedi-
atric Bells palsy: case report in a three-year-old child. J Altern
Complement Med 19(4):376382
39. Ng SY, Chu MHE (2014) Treatment of Bellspalsyusingmono-
chromatic infrared energy: a report of 2 cases. J Chiropractic Med
13(2):96103
40. Ushio M, Kondo K, Takeuchi N, Tojima H, Yamaguchi T, Kaga K
(2008) Prediction of the prognosis of Bells palsy using multivariate
analyses. Otol Neurotol 29(1):6972
PublishersnoteSpringer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Lasers Med Sci
... Currently, there is neither consensus nor clear guidelines on the optimal ideal standard treatment care for PFP; however, the following treatment modalities have been employed: pharmacotherapy (antiviral, corticosteroid and analgesic) [4,5], electrotherapy, biofeedback, facial massage, physical exercises, physiotherapy [6,7], acupuncture, electrical stimulation, botulinum toxin [8] and photobiomodulation [1,[9][10][11]. ...
... Even though idiopathic, viral/bacterial infection, neoplastic, toxic exposures, vascular ischemia, micro-trauma, autoimmune or even genetic reasons can be counted as responsible [10,11], reactivation of the herpes simplex virus-1 (HSV-1) at the cranial nerve is suspected to be the most common cause of facial nerve inflammation in BP [10]. This inflammation causes compression of the 7th cranial nerve at the geniculate ganglion and, subsequently, ischemia of the nerve. ...
... Even though idiopathic, viral/bacterial infection, neoplastic, toxic exposures, vascular ischemia, micro-trauma, autoimmune or even genetic reasons can be counted as responsible [10,11], reactivation of the herpes simplex virus-1 (HSV-1) at the cranial nerve is suspected to be the most common cause of facial nerve inflammation in BP [10]. This inflammation causes compression of the 7th cranial nerve at the geniculate ganglion and, subsequently, ischemia of the nerve. ...
Article
Full-text available
Peripheral facial paralysis (PFP) is a common condition where oxidative stress (OS) is involved in the pathophysiology of facial paralysis, inhibiting peripheral nerve regeneration, which can be featured in Bell's palsy, Ramsay Hunt syndrome and Lyme disease. The current standard care treatments lack consensus and clear guidelines. Hence, the utilization of the antioxidant im-munomodulator photobiomodulation (PBM) can optimize clinical outcomes in patients who are unresponsive to standard care treatments. Our study describes three unique cases of chronic PFP of various origins that were unresponsive to standard care treatments, but achieved a significant and complete recovery of facial paralysis following PBM therapy. Case presentations: Case #1: a 30-year-old male who presented with a history of 12 years of left-side facial paralysis and tingling as a result of Bell's palsy, where all the standard care treatments failed to restore the facial muscles' paralysis. Eleven trigger and affected points were irradiated with 1064 nm with an irradiance of 0.5 W/cm 2 delivered with a collimated prototype flat-top (6 cm 2) in a pulsed mode, with a 100 µs pulse duration at a frequency of 10 Hz for 60 s (s) per point. Each point received a fluence of 30 J/cm 2 according to the following treatment protocol: three times a week for the first three months, then twice a week for another three weeks, and finally once a week for the following three months. The results showed an improvement in facial muscles' functionality (FMF) by week two, whereas significant improvement was observed after 11 weeks of PBM, after which the House-Brackmann grading scale (HBGS) of facial nerve palsy dropped to 8 from 13 prior to the treatment. Six months after PBM commencement, electromyography (EMG) showed sustainability of the FMF. Case #2: A five-year-old female who presented with a 6-month history of severe facial paralysis due to Lyme disease. The same PBM parameters were utilized, but the treatment protocol was as follows: three times a week for one month (12 consecutive treatment sessions), then the patient received seven more sessions twice a week. During the same time period, the physiotherapy of the face muscles was also delivered intensively twice a week (10 consecutive treatments in five weeks). Significant improvements in FMF and sustainability over a 6-month follow-up were observed. Case #3: A 52-year-old male who presented with severe facial palsy (Grade 6 on HBGS) and was diagnosed with Ramsay Hunt syndrome. The same laser parameters were employed, but the treatment protocol was as follows: three times a week for three weeks, then reduced to twice a week for another three weeks, then weekly for the next three months. By week 12, the patient showed a significant FMF improvement, and by week 20, complete FMF had been restored. Our results, for the first time, showed pulsed 1064 nm PBM delivered with a flat-top handpiece protocol is a valid and its treatment protocol modified, depending on the origin and severity of the condition, which is fundamental in optimizing facial paralysis recovery and alleviating neurological symptoms. Further extensive studies with large data are warranted to validate our PBM dosimetry and treatment protocols.
... [11][12][13][14][15] PBMT, or low-level laser therapy, is a non-invasive and painless treatment that acts on the regeneration of neurons, increases microcirculation, activates angiogenesis, and heals the damaged peripheral nerves in both sensory and motor fibers. 11,[15][16][17][18] The absorption of photons by laser radiation is necessary to produce a photobiological response, particularly in the context of photobiomodulation. Chromophores -molecules capable of absorbing light at specific wavelengths -act as initial photoreceptors. ...
... Therefore, other therapeutic approaches, such as botulinum toxin, acupuncture, electrical stimulation, and PBMT, can be used to avoid significant sequelae. 11,[15][16][17][18]20 PBMT is a good therapeutic option as it is painless, has no adverse effects, and can be associated with other treatments. 11,[15][16][17][18]20 It acts on microcirculation, stimulating nerve regeneration and, consequently, accelerates the PFP's recovery process. ...
... 11,[15][16][17][18]20 PBMT is a good therapeutic option as it is painless, has no adverse effects, and can be associated with other treatments. 11,[15][16][17][18]20 It acts on microcirculation, stimulating nerve regeneration and, consequently, accelerates the PFP's recovery process. 11,[15][16][17][18]20 Although PBMT is associated with a shorter recovery period than drug therapies, a 3-month-long treatment may be necessary. ...
Article
Full-text available
Ramsay-Hunt syndrome is an infectious disease associated with the varicella-zoster virus, and peripheral facial palsy is often one of its clinical manifestations. This case report describes a patient diagnosed with Ramsay-Hunt syndrome who developed peripheral facial palsy and was treated by photobiomodulation therapy. A 26-year-old woman developed a lack of facial mobility on the right side, asymmetry, otalgia, dysgeusia, and dry eyes, leading to the diagnosis of Ramsay-Hunt syndrome. Her peripheral facial palsy was classified as moderately severe according to the House-Brackmann scale. Acyclovir, prednisone, and physiotherapy sessions were prescribed to manage peripheral facial palsy. In the absence of a clinical response to the proposed therapies, photobiomodulation therapy was employed using the parameters: 780 nm, 100 mW, 3 J/point, and 30.48 J/cm2. After five sessions of photobiomodulation therapy, complete recovery of facial movement was observed. Photobiomodulation therapy treated peripheral facial palsy effectively, allowing a fast recovery and avoiding irreversible sequelae in a patient with Ramsay-Hunt syndrome.
... Recently, Javaherian et al. [17] reviewed the possible use of photobiomodulation (PBM) in the treatment of BP and concluded a beneficial effect on recovery for patients with subacute BP; adverse effects were not described. Furthermore, in our previous systematic review [18], we showed PBM can affect the mitochondrial activity and the bioenergetics of cells, resulting in an improvement in the recovery from trigeminal diseases. ...
... Alternative approaches have been proposed [37,38], but in this case, the effective improvement with respect to placebo is still under evaluation [38]. Recently, PBM was proposed as an approach in the treatment of BP [17]. Tanganelli et al. [39], on a single patient, concluded that a single session of PBM therapy was an effective option for those affected by BP. ...
Article
Full-text available
Diminished facial movement and marked facial asymmetry can lead to a consistent psychological burden. Bell′s palsy (BP) is one of the most common causes of facial nerve illness, which comes with unilateral acute facial paresis. Nowadays, no clear guidelines for treating BP are available. We carried out a case series study to test the efficacy of photobiomodulation (PBM) therapy in patients with BP non-responsive to standard treatment. The study was experimentally performed at the Department of Surgical and Diagnostic Sciences, University of Genoa (Genoa, Italy), in accordance with case report guidelines. Patients were referred to our department by colleagues for evaluation to be included in the case series because no consistent improvement was observed at least 3 months from the diagnosis of BP. All the patients interrupted their pharmacological therapy before the initiation of PBM therapy. PBM therapy (808 nm, 1 W irradiated in continuous-wave for 60 s on spot-size 1 cm2; 1 W/cm2; 60 J/cm2; and 60 J) was administered every 2 days until complete resolution. Evaluation of the House-Brackmann scale was performed before and after treatments. Fourteen patients were screened as eligible for the study. Patients were Caucasians (36% females and 64% males) with a mean age ± standard deviation of 56.07 ± 15.21 years. Eleven patients out of 14, who experienced BP a maximum of 6 months, completely recovered through PBM. The three patients that did not show improvement were those who had experienced BP for years. PBM could be a supportive therapy for the management of BP in patients non-responsive to standard treatment. However, randomized controlled trials are necessary to sustain our encouraging results, exclude bias, and better explain the boundary between the time from diagnosis and the recovery of BP through PBM therapy.
... Different treatments have been proposed to achieve rapid recovery without significant sequelae. Such treatments include facial expression exercises [5], corticoids [1], antiviral drugs [6], electrical stimulation [7], and photobiomodulation therapy (PBMT) [8]. Although most patients recover from the functional nerve dysfunction, some patients exhibited an incomplete recovery [9]. ...
Article
Full-text available
To investigate the efficacy of laser acupuncture and photobiomodulation therapy in alleviating symptoms among patients diagnosed with Bell’s palsy with duration of greater than 8 weeks. The randomized controlled trial has been performed from May 2021 to April 2023. Patients were eligible who had Bell’s palsy with duration of greater than 8 weeks on out-patient Department of Otorhinolaryngology in Beijing Tongren Hospital. The laser acupuncture group received class IV laser treatment for 3 times per weeks, a total of 72 times. The control group received the same treatment procedure except the laser parameter. The primary outcome measures comprised House–Brackmann facial nerve grading system and electroneurography. Secondary outcome measures comprised Sunnybrook facial grading system, electromyography, and the blink reflex. A total of 84 participants were included (42 control group, 42 laser acupuncture group). After treatment, House–Brackmann facial nerve grading system (OR, 0.11; 95% CI, 0.04–0.30; P < 0.001), and the pathologic numbers of electroneuronography were statistically different between the laser acupuncture group and control group, including orbicularis oculi (OR,0.08; 95% CI, 0.02–0.21; P < 0.001), Frontalis muscle (OR,0.14; 95% CI, 0.05–0.39; P < 0.001), Orbicularis oris (OR,0.13; 95% CI, 0.04–0.36; P < 0.001), Ala nasi muscle (OR,0.06; 95% CI, 0.02–0.18; P < 0.001). In secondary outcomes, Sunnybrook facial grading system, has significant difference between the two groups (20.26; 95% CI, 14.69 to 25.83; P < 0.01). Latency by ENoG, include orbicularis oculi (-0.61; 95% CI, -0.43 to -0.09; P < 0.001), frontalis muscle (-0.12; 95% CI, -0.21 to -0.03; P < 0.01), orbicularis oris (-0.28; 95% CI, -0.41 to -0.16; P < 0.001), and ala nasi muscle (-0.26; 95% CI, -0.38 to -0.16; P < 0.001). All amplitudes of MUAPs and durations by electromyography (EMG) showed statistically significant differences compared with the control group after treatment. For the frontalis muscle, the amplitude of MUAPs was -64.23 (95% CI, -80.89 to -47.56; P < 0.001) and duration was -1.18 (95% CI, -1.49 to -0.87; P < 0.001). For orbicularis oris, amplitude of MUAPs was -29.82 (95% CI, -55.03 to -4.62; P = 0.02) and duration was -0.57 (95% CI, -0.94 to -0.20; P < 0.001). For depressor angulli oris, amplitude of MUAPs was -47.06 (95% CI, -62.15 to -31.97; P < 0.001) and duration was -2.21 (95% CI, -2.69 to -1.72; P < 0.001). Blink reflex, including R1 (OR, 0.03; 95% CI, 0.01–0.16; P < .001), R2 (OR, 0.04; 95% CI, 0.004–0.29; P < .001), and R2 latency differences (OR, 0.15; 95% CI, 0.05–0.51; P < .001), have significant difference between the two groups, respectively. The findings suggest that laser acupuncture relieve symptoms for patients with Bell’s palsy with a duration of greater than 8 weeks. Trial registration: ClinicalTrials.gov Identifier: NCT05846217.
... This study found that the intervention frequency was an influencing factor of the effect of LLLT on burning pain. Consistent with previous systematic reviews, LLLT, 1 or 2 times per week, more than 4 weeks of intervention, was beneficial for reducing burning pain intensity in patients with BMS [49,50]. This suggested that the effect of LLLT progresses over time and could maximize treatment results [51]. ...
Article
Full-text available
Background Burning mouth syndrome (BMS) is a complex chronic pain disorder that significantly impairs patients' quality of life. Low-level laser therapy (LLLT) uses infrared or near-infrared light to produce analgesic, anti-inflammatory, and biological stimulation effects. The aim of this systematic review is to evaluate the effect of LLLT on burning pain, quality of life, and negative emotions in patients with BMS. Methods The PubMed, Embase, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Cochrane Library, Web of Science, and Scopus databases were searched up January 2023 to identify relevant articles. All randomized controlled trials that were published in English and examined the use of LLLT treatment for BMS were included. The methodological quality of the included trials was assessed using the Cochrane risk of bias tool for randomized controlled trials (RCTs). A meta-analysis was performed to evaluate burning pain, quality of life, and negative emotions. Sensitivity, subgroup, and funnel plot analyses were also carried out. Results Fourteen RCTs involving a total of 550 patients with BMS met the inclusion criteria. The results showed that LLLT (measured by the Visual Analog Scale; SMD: -0.87, 95% CI: -1.29 to -0.45, P < 0.001) was more effective for reducing burning pain than placebo LLLT or clonazepam. LLLT improved quality of life (evaluated by the Oral Health Impact Profile-14; SMD: 0.01, 95% CI: -0.58 to 0.60, P = 0.97) and negative emotions (evaluated by the Hospital Anxiety and Depression Scale; SMD: -0.12, 95% CI: -0.54 to 0.30, P = 0.59), but these effects were not statistically significant. Conclusions The meta-analysis revealed that LLLT may be an effective therapy for improving burning pain in patients with BMS, and producing a positive influence on quality of life and negative emotions. A long-term course of intervention, a larger sample size, and a multidisciplinary intervention design are urgently needed in future research. Trial registration PROSPERO registration number: CRD42022308770.
... However, inconsistent results have been reported using current rehabilitative techniques [8]. All precedent reviews can be categorized as low-quality evidence [9]. Furthermore, a systematic review published to date has only illuminated low-level laser therapy's impact on Bell's palsy. ...
Article
Full-text available
(1) Background: Facial palsy is a common health issue which leads to sequelae and disability. This systematic review aimed to assess the efficacy of laser therapy for the treatment of facial palsy. (2) Methods: Only randomized controlled trials comparing the effectiveness of laser therapy to non-laser intervention, no intervention, or placebo were searched for. Relevant studies were searched in seven electronic databases. Studies that examined the use of laser modalities for facial palsy management, with or without acupuncture, were also included. Two authors independently read and scored the methodological quality of the selected texts, and any disagreement was resolved by discussion or by intervention from the third author. (3) Results and conclusions: With five full-text articles, a methodological quality for each included study was assessed (kappa coefficient = 0.75). The laser therapy group in the mean difference measuring FDI showed an effect size of 8.15 compared to the control group; while measuring the paralysis score, an advantage was disclosed with an effect size of 0.22 compared to the control group.
... The annual incidence of Bell's palsy is 23 to 35 cases per 100,000 with an equal gender ratio. It is thought that 50-75% of acute unilateral facial paralysis appeared between 30 and 50 years old (Javaherian M et al., 2020) Though the causes of this illness are unknown it is believed to be associated with hypercholesterolemia, hypertension, diabetes, infections, poisoning, genetic syndromes, neoplasia, and musculoskeletal and neurological lesions (Ramos-Jimenez A et al., 2015). Some evidence proposed that herpes simplex virus-1 reactivation at the cranial nerve is the most strongly suspected cause of facial nerve inflammation in Bell's palsy (Zandian A et al., 2014) The prognosis of Bell's palsy is relevant the depends on factors such as time of recovery, age, pain behind the ear, taste distribution, and genetics (Katusic SK et al., 1986, Dalla Toffola E et al., 2012. ...
Article
Full-text available
Bell's Palsy is one of the most common mononeuropathies or disorders affecting a single nerve and is associated with facial nerve weakness and paralysis. Though self-limiting the disorder may leave its long-lasting residual manifestations in the form of abnormal facial symmetry, inability to close the eyes, and other poor outcomes leading to disability and impairment in societal functioning among patients. Treatment strategies include pharmacological, surgical, and therapeutic options and to limit the long-term devastating effects therapeutic options play a vital role. Physiotherapeutic techniques have been widely used among patients with Bell's Palsy but not all techniques are performed in combination. One is compared with the other and also for short durations. We planned this study to see the outcome of combined techniques available in Physiotherapy on a patient with long-term follow-up. This is a case of 38 years old male patient diagnosed with right-sided bell palsy who received 7 weeks of rehabilitation in the form of electrotherapy, facial exercises, facial PNF, massage, and education on eye care. The implementation of 7 weeks of physiotherapeutic rehabilitation led to improved facial functions and a reduction in the level of disability in the patient.
... Insgesamt gesehen sind somit die Studien zur Übungsbehandlung und anderen nicht medikamentösen Therapien (wie z. B. auch Lasertherapie [59]) sehr inhomogen und erlauben keine klare Empfehlung. In der klinischen Praxis können aber psychologische Gründe dazu veranlassen, zu einer Übungsbehandlung zu raten (nach kurzer Anleitung und unter Selbstkontrolle vor dem Spiegel). ...
Article
Full-text available
Objective: To determine whether photobiomodulation therapy (PBMT) by class IV Multiwave Locked System laser treatment as an adjunctive therapy could relieve symptoms in patients with Bell's palsy with a duration of greater than 8 weeks. Materials and methods: This nonrandomized controlled trial was conducted from January 2020 to December 2022. Patients were eligible if they had Bell's palsy with a duration of greater than 8 weeks at the out-patient department of otorhinolaryngology in Beijing Tongren Hospital. The control group consisted of patients recruited between January 1, 2020, and December 31, 2020. The PBMT group consisted of patients recruited between January 1, 2021, and December 31, 2022. In this study, the PBM used has a wavelength of 808 and 905 nm, 1.2 W power (808 nm is 1 W, 905 nm is 200 mW), continuous mode emission (808 nm) and pulsed mode emission (905 nm), 8.35 J/cm2 dosimetry, administered 3 times per week, 72 times of total treatment. The primary outcome measures included the House-Brackmann facial nerve grading system, the Sunnybrook facial grading system, and the Facial Clinimetric Evaluation Scale (FaCE). Secondary outcome measures comprised electroneurography, electromyography, and the blink reflex. Results: A total of 54 participants were included (27 in the control group and 27 in the photobiomodulation group). After 6 months, the House-Brackmann grading system [risk difference, -0.59, confidence interval (95% CI), -0.81 to -0.38, relative risk, 0.27, 95% CI, 0.13-0.56, p < 0.001], Sunnybrook facial grading system (21.14, 95% CI, 11.71-30.58; p < 0.001), and FaCE (-0.20, 95% CI, 0.41-0.02; p = 0.07) had significant difference between the two groups. Latency of ala nasi muscle (10.92, 95% CI, 5.58-16.27; p < 0.001) was not statistically significant after treatment compared with the control group; however, most of the electrophysiological examinations have significant difference between the two groups, respectively. Conclusions: The results of this study suggest that PBMT may relieve symptoms for patients with Bell's palsy with a duration of greater than 8 weeks. Trial Registration: ClinicalTrials.gov Identifier: NCT05585333.
Article
Full-text available
We performed this meta-analysis to investigate the efficacy of low-level laser therapy (LLLT), a physiotherapy modality with anti-inflammatory and analgesic effects, in the management of mild-to-moderate carpal tunnel syndrome (CTS). We searched PubMed, Web of Knowledge, Scopus, Cochrane Central, and Virtual Health Library for randomized controlled trials (RCTs) that compared the effects of LLLT with or without splinting versus placebo on functional and electromyographic outcomes in CTS. All outcomes were pooled as mean differences (MD) under the inverse variance or random effects model, using the statistical add-in (MetaXL, version 5.0). Eight RCTs (473 patients/631 wrists) were eligible for the final analysis. The overall effect estimates did not favor LLLT therapy group over placebo in all primary outcomes: visual analogue scale (MD -1.11, 95% CI [-2.58, 0.35]), symptom severity scale score (MD -1.41, 95% CI [-5.12, 2.29]), and functional status scale score (MD -1.33, 95% CI [-3.27, 0.61]). However, LLLT was superior to placebo in terms of grip strength (MD 2.19, 95% CI [1.63, 2.76]) and inferior to placebo in terms of sensory nerve action potential (MD -2.74, 95% CI [-3.66, -1.82]). Laser therapy is superior to placebo in terms of improving the grip strength; however, no significant difference was found between both groups in terms of functional status improvement, pain reduction, or motor electrodiagnostic evaluations. Further high-quality trials with longer follow-up periods are required to establish the efficacy of LLLT for CTS treatment.
Article
Full-text available
The aim of the present study was to investigate the efficacy of low-level laser therapy in conjunction with conventional facial exercise treatment on functional outcomes during the early recovery period in patients with facial paralysis. Forty-six patients (mean age: 41 ± 9.7 years; 40 women, 6 men) were randomized into two groups. Patients in the first group received low-level laser treatment as well as facial exercise treatment, while patients in the second group participated in facial exercise intervention alone. Laser treatment was administered at a wavelength of (830 nm, output power of 100 Mw, and frequency of 1 KHz) using a gallium-aluminum-arsenide (GaAIAs, infrared laser) diode laser. A mean energy density of 10 J/cm² was administered to eight points of the affected side of the face three times per week, for a total of 6 weeks. The rate of facial improvement was evaluated using the Facial Disability Index (FDI) before, 3 weeks after, and 6 weeks after treatment. Friedman analysis of variance was performed to compare the data from the parameters repeatedly measured in the inner group analysis. Bonferroni correction was performed to compare between groups as a post hoc test if the variance analysis test result was significant. To detect the group differences, the Bonferroni Student t-test was used. The Mann-Whitney U-test was used to compare numeric data between the groups. In the exercise group, although no significant difference in FDI scores was noted between the start of treatment and week 3 (P<0.05), significant improvement was observed at week 6 (p<0.001). In the laser group, significant improvement in FDI scores relative to baseline was observed at 3 and 6 weeks (p<0.001). Improvements in FDI scores were significantly greater at weeks 3 and 6 in the laser group than in the exercise group (p<0.05). Our findings indicate that combined treatment with LLLT and exercise therapy is associated with significant improvements in FDI when compared with exercise therapy alone.
Article
Full-text available
Photobiomodulation also known as low-level laser (or light) therapy (LLLT), has been known for almost 50 years but still has not gained widespread acceptance, largely due to uncertainty about the molecular, cellular, and tissular mechanisms of action. However, in recent years, much knowledge has been gained in this area, which will be summarized in this review. One of the most important chromophores is cytochrome c oxidase (unit IV in the mitochondrial respiratory chain), which contains both heme and copper centers and absorbs light into the near-infrared region. The leading hypothesis is that the photons dissociate inhibitory nitric oxide from the enzyme, leading to an increase in electron transport, mitochondrial membrane potential, and adenosine triphosphate production. Another hypothesis concerns light-sensitive ion channels that can be activated allowing calcium (Ca2+) to enter the cell. After the initial photon absorption events, numerous signaling pathways are activated via reactive oxygen species, cyclic AMP, NO, and Ca2+, leading to activation of transcription factors. These transcription factors can lead to increased expression of genes related to protein synthesis, cell migration and proliferation, anti-inflammatory signaling, anti-apoptotic proteins, and antioxidant enzymes. Stem cells and progenitor cells appear to be particularly susceptible to LLLT.
Article
Full-text available
Background: Aggressive, or even minimally aggressive, aesthetic interventions are almost inevitably followed by such events as discomfort, erythema, edema and hematoma formation which could lengthen patient downtime and represent a major problem to the surgeon. Recently, low level light therapy with light-emitting diodes (LED-LLLT) at 830 nm has attracted attention in wound healing indications for its anti-inflammatory effects and control of erythema, edema and bruising. Rationale: The wavelength of 830 nm offers deep penetration into living biological tissue, including bone. A new-generation of 830 nm LEDs, based on those developed in the NASA Space Medicine Laboratory, has enabled the construction of planar array-based LED-LLLT systems with clinically useful irradiances. Irradiation with 830 nm energy has been shown in vitro and in vivo to increase the action potential of epidermal and dermal cells significantly. The response of the inflammatory stage cells is enhanced both in terms of function and trophic factor release, and fibroblasts demonstrate superior collagenesis and elastinogenesis. Conclusions: A growing body of clinical evidence is showing that applying 830 nm LED-LLLT as soon as possible post-procedure, both invasive and noninvasive, successfully hastens the resolution of sequelae associated with patient downtime in addition to significantly speeding up frank wound healing. This article reviews that evidence, and attempts to show that 830 nm LED-LLLT delivers swift resolution of postoperative sequelae, minimizes downtime and enhances patient satisfaction.
Article
Full-text available
Acupuncture has emerged as an alternative therapy for Bell's palsy in both adults and children. However, the use of acupuncture is controversial. We conducted a systematic review and meta-analysis to assess the efficacy of acupuncture for Bell's palsy. We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials, irrespective of any language restrictions. Randomized controlled trials comparing acupuncture with other therapies for Bell's palsy in adults or children were included. Fourteen randomized controlled trials involving 1541 individuals were included in this meta-analysis. Significant association was observed in acupuncture with a higher effective response rate for Bell's palsy (relative risk, 1.14; 95% confidence interval, 1.04-1.25; P = 0.005) but there was a heterogeneity among the studies (I2 = 87%). An assessment of the included studies revealed a high risk of bias in methodological quality. An evaluation of the incidence of complications was not available, owing to incomplete data. Acupuncture seems to be an effective therapy for Bell's palsy, but there was insufficient evidence to support the efficacy and safety of acupuncture. However, the results should be interpreted cautiously, because of the poor quality and heterogeneity of the included studies.
Article
Full-text available
Bell's palsy is a common cranial neuropathy causing acute unilateral lower motor neuron facial paralysis. Immune, infective and ischaemic mechanisms are all potential contributors to the development of Bell's palsy, but the precise cause remains unclear. Advancements in the understanding of intra-axonal signal molecules and the molecular mechanisms underpinning Wallerian degeneration may further delineate its pathogenesis along with in vitro studies of virus-axon interactions. Recently published guidelines for the acute treatment of Bell's palsy advocate for steroid monotherapy, although controversy exists over whether combined corticosteroids and antivirals may possibly have a beneficial role in select cases of severe Bell's palsy. For those with longstanding sequaelae from incomplete recovery, aesthetic, functional (nasal patency, eye closure, speech and swallowing) and psychological considerations need to be addressed by the treating team. Increasingly, multidisciplinary collaboration between interested clinicians from a wide variety of subspecialties has proven effective. A patient centred approach utilising physiotherapy, targeted botulinum toxin injection and selective surgical intervention has reduced the burden of long-term disability in facial palsy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Article
Transcranial infrared laser stimulation (TILS) is a noninvasive form of brain photobiomulation. Cytochrome-c-oxidase (CCO), the terminal enzyme in the mitochondrial electron transport chain, is hypothesized to be the primary intracellular photoacceptor. We hypothesized that TILS up-regulates cerebral CCO and causes hemodynamic changes. We delivered 1064-nm laser stimulation to the forehead of healthy participants ( n = 11), while broadband near-infrared spectroscopy was utilized to acquire light reflectance from the TILS-treated cortical region before, during, and after TILS. Placebo experiments were also performed for accurate comparison. Time course of spectroscopic readings were analyzed and fitted to the modified Beer-Lambert law. With respect to the placebo readings, we observed (1) significant increases in cerebral concentrations of oxidized CCO (Δ[CCO]; >0.08 µM; p < 0.01), oxygenated hemoglobin (Δ[HbO]; >0.8 µM; p < 0.01), and total hemoglobin (Δ[HbT]; >0.5 µM; p < 0.01) during and after TILS, and (2) linear interplays between Δ[CCO] versus Δ[HbO] and between Δ[CCO] versus Δ[HbT]. Ratios of Δ[CCO]/Δ[HbO] and Δ[CCO]/Δ[HbT] were introduced as TILS-induced metabolic-hemodynamic coupling indices to quantify the coupling strength between TILS-enhanced cerebral metabolism and blood oxygen supply. This study provides the first demonstration that TILS causes up-regulation of oxidized CCO in the human brain, and contributes important insight into the physiological mechanisms.
Article
Background. The authors studied the dynamics of the improvement of facial muscle motor function in children with peripheral facial nerve paresis. The objective of the present investigations is the comparison of the therapeutic effect achieved in children with peripheral facial nerve paresis using neurophysiological stimulation with the effects obtained with laser biostimulation and electrostimulation. Material and methods. 51 children with peripheral damage of the facial nerve symptoms were examined. To assess the function of the above muscles, a "0" to "3" score scale developed by Pietruski was used. The children were divided into three groups: Group 1 (N=17) received laser biostimulation (4-6 J/cm2, 3-4 procedures per week, 20 procedures per series, a CTL-1106 MX 830 nm, 400 mW laser manufactured by Laser Instruments); Group 2 children (N=17) were subjected to a therapy that combined elements of three neurophysiological methods: the reflex therapy developed by Vojta, method PNF and elements of the Castillo-Morales method; Group 3 patients (N=17) were subjected to impulse electrostimulation (an Pulsotronic ST-5D electrostimulator manufactured, with impulse duration of 80-180 ms, frequency of 1 - 4 Hz and amplitude of 20 - 60 mA). All the children were subjected to passive, passive-active and active motor exercises of the facial muscles and delicate massage. Results. In the first examination at the beginning of therapy, mimical muscle function was poor and the score low: in Group 1 - 4.2, Group 2 - 4.8 and in Group 3 - 6.2. In consequence of various types of stimulatory treatment, the mean time of muscle function restoration in the investigated patients was as follows: Group 1 - 33.4 days, Group 2 - 22,9 days and Group 3-41.7 days. Conclusion. Reflex forms of therapy using the methods of PNF, Castillo-Morales and Vojta constitute an effective and commonly available rehabilitative treatment modality in peripheral damage to the facial nerve. Effectiveness of electrostimulation turn out to be very low that is why using this method in peripheral facial nerve paralysis treatment isn't crucial.
Article
Background: Facial palsy is one of the most common mononeuropathy in children. Objective: This study was conducted to examine the effects of low intensity laser therapy (LILT) on regeneration rate of the facial nerve in children as a peripheral nerve model. Methods: 35 children age ranged from 4 to10 years with unilateral peripheral facial palsy, were assigned randomly to four groups. Compound motor action potential (CMAP) of facial nerve was measured before treatment. Subjects in three study groups were treated for 12 sessions in four weeks with Gallium aluminum arsenide (Ga.Al.As) diode laser irradiation (power = 30 mW / wavelength = 830 nm / continuous wave / spot size = 4 mm 2 / angle of divergence = 2.5° / penetration dose = 8 mm) on the facial nerve trunk and facial muscles, with different irradiation doses 0.4 J/cm 2 for 15 minutes, 6 J/cm 2 for 30 minutes and 4 J/cm 2 for 20 minutes, whereas subjects in the control group were treated by placebo laser. All subjects in the study and control groups received the traditional physiotherapy program. Reevaluation was performed after final session Results: LILT of energy density 4 J/cm 2 for 20 minutes significantly increased CMAP amplitude and decreased the degeneration percent of the affected facial nerve more than laser with other energy and the traditional physiotherapy program. CMAP latency of the affected facial nerve did not change. Conclusion: LILT increases the regeneration rate of the facial nerve as a peripheral nerve model at least at the parameters and dose-regimen used in present study.
Article
The choice of the motor donor nerve is a crucial point for free flap transfer algorithms. In case of unilateral facial paralysis, the contralateral healthy facial nerve can provide coordinated smile animation and spontaneous emotional expression, but with unpredictable axonal ingrowth into the recipient muscle. Otherwise, the masseteric nerve ipsilateral to the paralysis can provide a powerful neural input, without a spontaneous trigger of the smile. Harvesting a bulky muscular free-flap may enhance quantity of contraction but esthetic results are unpleasant. So, the logical solution to obtain high amplitude of smiling combined with the spontaneity of movement is to couple neural input: the contralateral facial nerve plus the ipsilateral masseteric nerve.